Episode 58: PYLARIFY® Injection PET/CT Imaging in Prostate Cancer Patient for UroNurse episode artwork

EPISODE · Sep 9, 2023 · 51 MIN

Episode 58: PYLARIFY® Injection PET/CT Imaging in Prostate Cancer Patient for UroNurse

from UroNurse · host UroNurse

Marco Carlos MA, Patient Navigator at Urology of Austin will discuss PYLARIFY® (piflufolastat F 18) Injection used in PET/CT imaging for the detection of prostate cancer in patients. PYLARIFY is a diagnostic imaging agent that contains the radioactive isotope fluorine-18 (F 18) attached to a molecule called piflufolastat. This radiopharmaceutical is used to visualize specific biological processes in the body. Prostate cancer cells have an increased expression of a molecule called prostate-specific membrane antigen (PSMA). PYLARIFY is designed to bind to PSMA receptors on the surface of prostate cancer cells. By attaching F 18 to piflufolastat, PYLARIFY can be detected using positron emission tomography (PET) imaging, which produces detailed images of the distribution of this radiopharmaceutical in the body. *The information provided in this video is for entertainment and educational purposes only, and does not constitute medical advice. Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment. #prostate #prostatecancer #petscan

Marco Carlos MA, Patient Navigator at Urology of Austin will discuss PYLARIFY® (piflufolastat F 18) Injection used in PET/CT imaging for the detection of prostate cancer in patients. PYLARIFY is a diagnostic imaging agent that contains the radioactive isotope fluorine-18 (F 18) attached to a molecule called piflufolastat. This radiopharmaceutical is used to visualize specific biological processes in the body. Prostate cancer cells have an increased expression of a molecule called prostate-specific membrane antigen (PSMA). PYLARIFY is designed to bind to PSMA receptors on the surface of prostate cancer cells. By attaching F 18 to piflufolastat, PYLARIFY can be detected using positron emission tomography (PET) imaging, which produces detailed images of the distribution of this radiopharmaceutical in the body. *The information provided in this video is for entertainment and educational purposes only, and does not constitute medical advice. Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment. #prostate #prostatecancer #petscan

NOW PLAYING

Episode 58: PYLARIFY® Injection PET/CT Imaging in Prostate Cancer Patient for UroNurse

0:00 51:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of UroNurse?

This episode is 51 minutes long.

When was this UroNurse episode published?

This episode was published on September 9, 2023.

What is this episode about?

Marco Carlos MA, Patient Navigator at Urology of Austin will discuss PYLARIFY® (piflufolastat F 18) Injection used in PET/CT imaging for the detection of prostate cancer in patients. PYLARIFY is a diagnostic imaging agent that contains the...

Can I download this UroNurse episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!